Varro Life Sciences’ Academic Partners at Washington University in St. Louis Received $3.6 Million Dollar Grant

Technology developed by Washington University in St. Louis that detects SARS-CoV-2 and other viral, bacterial, and fungal pathogens in people and spaces in under 60 seconds

Addressing new threats:  In the event a new pathogenic threat emerges, Varro can create a detector within four weeks or less of receiving the sample, enabling faster development of new diagnostic tests than any other technology

Funded research: Through NIH RADx RAD and other public and private sources

Products: Create biosensors that substantially reduce large-scale infectious disease testing times, and costs, and improve aerosolized pathogen detection sensitivity and specificity.  Create biodetector devices which are inexpensive, easy to operate, and provide results in under 60 seconds with the accuracy of qPCR.

Continue reading the full press release on the University of Washington in St. Louis website here.